Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 19Neoplasms 18Cancer Pain 6Breast Neoplasms 5Breakthrough Pain 5Prostatic Neoplasms 4Lung Neoplasms 4Colonic Neoplasms 4Agnosia 4Rectal Neoplasms 3Pancreatic Neoplasms 3Head and Neck Neoplasms 3Chronic Pain 3Uterine Cervical Neoplasms 2Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain, Postoperative 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Hepatocellular 2Burns 2Anemia, Sickle Cell 2post laminectomy syndrome 1Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vipoma 1Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1

Interventions

Fentanyl 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Failed Back Surgery Syndrome × Fentanyl × Clear all
NCT03523000 2023-01-12

Determining the Prognostic Value of Continuous Intrathecal Infusion

University Hospitals Cleveland Medical Center

Phase 4 Completed
36 enrolled 14 charts

post laminectomy syndrome, Failed Back Surgery Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡